Optimal medical therapy (OMT)
Sponsors
Duke University, The University of Texas Health Science Center, Houston, Helios Health Institute GmbH, Charite University, Berlin, Germany, University of Aarhus
Conditions
Coronary Artery DiseaseCoronary Artery Disease (CAD)Heart FailureMitral Valve InsufficiencyMyocardial InfarctionPercutaneous Transluminal AngioplastyRenal Artery Stenosis AtheroscleroticRenovascular Hypertension
Phase 3
Unknown Phase
Combined Pressure and Flow Measurements to Guide Treatment of Coronary Stenoses
CompletedNCT02328820
Start: 2014-10-31End: 2021-04-30Updated: 2021-04-06
Personalised Risk scOre For Implantation of Defibrillators in Patients With Preserved LVEF>35% and a High Risk for Sudden Cardiac Death
WithdrawnNCT04540289
Start: 2021-02-01End: 2023-01-31Updated: 2023-03-08
Personalised Risk scOre For Implantation of Defibrillators in Patients With Reduced LVEF≤35% and a Low Risk for Sudden Cardiac Death
WithdrawnNCT04540354
Start: 2021-02-01End: 2023-01-31Updated: 2023-03-08
Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation
RecruitingNCT05665608
Start: 2023-11-16End: 2027-11-30Target: 3595Updated: 2026-04-01
Effects of Percutaneous Transluminal Renal Angioplasty of Atherosclerotic Renal Artery Stenosis in High-Risk Patients.
RecruitingNCT05834803
Start: 2023-06-26End: 2027-06-01Target: 80Updated: 2026-04-23
Micro-axial Flow Pump-Supported PCI in Complex Coronary Artery Disease With Ischemic LV Dysfunction
Not yet recruitingNCT07678021
Start: 2026-08-01End: 2029-12-31Target: 452Updated: 2026-07-01
A Study to Evaluate the Safety and Performance of TruGamma System for Tricuspid Replacement
RecruitingNCT07691307
Start: 2026-03-18End: 2028-08-30Target: 180Updated: 2026-07-08